Why Switch to Wegovy 1mg? Cost & Clinical Benefits
Switching Medications: Wegovy 1mg Side Effects Profile
When switching from Mounjaro (tirzepatide) or diabetes-licensed semaglutide to Wegovy 1mg, understanding the side effect profile helps ensure a smooth transition. Wegovy 1mg side effects typically include nausea, diarrhoea, vomiting, and constipation, with most patients experiencing these symptoms mildly during the initial weeks. Many patients find Wegovy's side effect profile more manageable than their previous GLP-1 medication, particularly when switching due to tolerability issues. The 1mg dose represents weeks 9-12 of escalation, where your body has had time to adjust to lower doses first.
Patients switching to Wegovy 1mg often report improved gastrointestinal tolerance compared to equivalent doses of other medications. This prescription-only medicine works as a GLP-1 receptor agonist, and the side effects generally diminish as your body adapts. Our clinical team provides switching protocols to help minimise Wegovy 1mg side effects during transition. EverydayMeds stocks both Wegovy and Mounjaro, making your switch seamless from a single GPhC-registered pharmacy.
Switch & Save: Wegovy 1mg Pricing Advantage
The financial benefits of switching to Wegovy 1mg are substantial, with our pricing at £99.99 per pen representing significant savings over high street alternatives. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive rates. Our Advance Duo bundle (1mg + 1.7mg) costs £269.99, providing a smooth progression to higher doses without multiple orders. The Consistency 1mg bundle offers two 1mg pens for £209.99, perfect for patients who need to remain at this dose longer.
Compared to Mounjaro's typical pricing, switching to Wegovy 1mg can save patients hundreds of pounds annually whilst maintaining effective weight management support. The cold-chain delivery ensures your medication arrives in perfect condition, eliminating concerns about temperature stability during switching. Our 3-minute clinical assessment streamlines the prescription process, with standard prescriber review taking 3 working days or express 24-hour options available. These savings make long-term weight management more sustainable for patients committed to their health journey.
Clinical Evidence: Wegovy 1mg Side Effects in STEP Trials
The STEP clinical trials provide comprehensive data on Wegovy 1mg side effects, with Wilding et al., NEJM, 2021, demonstrating that patients taking Wegovy alongside diet and exercise experienced manageable side effect profiles. Most Wegovy 1mg side effects were gastrointestinal and transient, typically resolving within the first few weeks of treatment. The trials showed that patients who experienced side effects at 1mg often saw improvement as they continued treatment.
In clinical trials, the 1mg dose served as an important escalation step, with side effects generally less severe than at higher maintenance doses. The evidence suggests that Wegovy 1mg side effects are dose-dependent and time-limited for most patients. Trial data indicates that patients switching from other GLP-1 medications often experienced fewer side effects when transitioning gradually through the Wegovy dose escalation protocol.
Understanding Wegovy 1mg Side Effects Mechanism
Wegovy works as a GLP-1 receptor agonist, mimicking natural fullness hormones that regulate appetite and digestion. The side effects you may experience with Wegovy 1mg stem from this mechanism, as the medication slows gastric emptying and affects gut motility. This prescription-only medicine reduces appetite by working on brain appetite centres, which can initially cause nausea or changes in digestion patterns. The 1mg dose provides substantial appetite regulation whilst remaining within the escalation phase, allowing your body to adapt gradually. Most patients find that Wegovy 1mg side effects diminish significantly within 2-4 weeks as their digestive system adjusts to the medication's effects. Understanding this mechanism helps patients recognise that side effects are often temporary and indicative of the medication working effectively.
Streamlined Ordering Process for Medication Switching
Switching to Wegovy 1mg through EverydayMeds involves a straightforward 3-minute online clinical assessment that captures your current medication details and switching rationale. Our prescribers review your case within 3 working days (or 24 hours with express service), considering your previous GLP-1 experience and any side effects that prompted the switch. Once approved, your Wegovy 1mg is dispatched via next-day delivery using specialist cold-chain transport to maintain the 2-8°C storage requirements. The process includes switching guidance documentation to help you transition safely from your current medication. Our clinical team remains available for questions about Wegovy 1mg side effects during your transition period, ensuring you feel supported throughout the switching process.
Storage and Practical Switching Considerations
Wegovy 1mg arrives in FlexTouch pre-filled pens requiring refrigeration at 2-8°C until first use, after which they remain stable for up to 6 weeks at room temperature below 30°C. This storage flexibility provides significant advantages over Mounjaro's 21-day room temperature limit, making Wegovy ideal for patients who travel or prefer flexible storage options. The dose escalation protocol means 1mg represents weeks 9-12 of treatment, so timing your switch appropriately with your prescriber's guidance is essential. Each pen contains 4 doses of 0.25mg increments, though you'll inject the full 1mg weekly as prescribed. Proper injection technique remains consistent across GLP-1 medications, making the practical transition straightforward for experienced patients. The pen's design includes dose confirmation features to ensure accurate administration during your switching period.
Minimising Wegovy 1mg Side Effects During Medication Transition
Successful switching to Wegovy 1mg involves timing your transition to minimise overlapping side effects from discontinuing your previous medication. Our clinical guidance recommends specific washout periods depending on your current GLP-1 medication, helping prevent compounded gastrointestinal effects. Patients often find that switching directly to 1mg (rather than starting from 0.25mg) is appropriate when transitioning from equivalent doses of other GLP-1 medications, though individual tolerance varies.
The key to minimising Wegovy 1mg side effects lies in maintaining consistent meal patterns and staying well-hydrated during the transition period. Many patients report that the side effect profile feels more predictable with Wegovy compared to their previous medication, particularly regarding timing and severity. Starting with smaller, more frequent meals can help manage any gastrointestinal adjustment as your body adapts to the new medication formulation.
Complete Your Switch to Wegovy 1mg Today
Ready to switch and save with Wegovy 1mg at £99.99? Our clinical assessment takes just 3 minutes and captures all relevant details about your current medication and switching goals. New customers can use discount code FIRST40 at checkout, whilst returning customers apply DOSE25 to access our competitive pricing. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and complete your switch today. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine Wegovy with full clinical support throughout your transition. The combination of significant cost savings, clinical expertise, and seamless switching support makes EverydayMeds your ideal partner for weight management success.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
